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The Polycomb protein Ezl1 mediates H3K9 and
H3K27 methylation to repress transposable
elements in Paramecium
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In animals and plants, the H3K9me3 and H3K27me3 chromatin silencing marks are deposited
by different protein machineries. H3K9me3 is catalyzed by the SET-domain SU(VAR)3–9
enzymes, while H3K27me3 is catalyzed by the SET-domain Enhancer-of-zeste enzymes,
which are the catalytic subunits of Polycomb Repressive Complex 2 (PRC2). Here, we show
that the Enhancer-of-zeste-like protein Ezl1 from the unicellular eukaryote Paramecium tet-
raurelia, which exhibits significant sequence and structural similarities with human EZH2,
catalyzes methylation of histone H3 in vitro and in vivo with an apparent specificity toward
K9 and K27. We find that H3K9me3 and H3K27me3 co-occur at multiple families of
transposable elements in an Ezl1-dependent manner. We demonstrate that loss of these
histone marks results in global transcriptional hyperactivation of transposable elements with
modest effects on protein-coding gene expression. Our study suggests that although often
considered functionally distinct, H3K9me3 and H3K27me3 may share a common evolu-
tionary history as well as a common ancestral role in silencing transposable elements.
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Post translational modifications of histones play essentialroles in DNA transactions at the level of chromatin. Amongthese modifications, trimethylation of histone H3 on lysine
9 (H3K9me3) and lysine 27 (H3K27me3) are typically associated
with transcriptionally silent chromatin. These two epigenetic
signatures are controlled by distinct families of histone methyl-
transferases. H3K9me3 is catalyzed by the SET-domain SU(VAR)
3–9 enzymes1–5, while H3K27me3 is installed by the SET-domain
Enhancer-of-zeste enzymes, acting as the catalytic subunits of
Polycomb Repressive Complex 2 (PRC2)6–9.
It is widely believed that H3K9me3 and H3K27me3 do not co-
occur at the same genomic loci, and this assumption is supported
by evidence from several organisms. In human and fly, the
majority of H3K9me3-enriched domains are concentrated at
repeated DNA sequences, such as transposable elements and
satellites, and repress the transcription of the underlying
repeats10–13. In contrast, H3K27me3 is involved in the stable and
heritable maintenance of cell-type-specific gene repression14.
However, this view has come to be challenged by examples of
co-occurrence of H3K9me3 and H3K27me3. Indeed, ChIP-seq
data indicate that these two marks can be found together at a
subset of developmentally regulated genes in mouse embryonic
stem cells, extra-embryonic lineages and human differentiated
cells15–17. In addition, mass spectrometry experiments have
demonstrated that H3K27me3 can coexist with H3K9me3 on the
same histone octamer in embryonic stem cells18.
An increasing body of evidence suggests that the two types of
silent chromatin can compensate for each other, and that
H3K9me3 usually prevents the installation of H3K27me3. In
mouse embryonic stem cells, the loss of H3K9me3 at pericen-
tromeric regions that occurs upon knockout of SUV39H1
enzymes is accompanied by ectopic establishment of
H3K27me313. Moreover, in several human cancer cell lines,
pericentromeric regions show massive recruitment of Polycomb
Group proteins19,20. H3K27me3 has also been shown to re-
localize to and silence transposons in mouse embryonic stem cells
upon loss of DNA methylation21,22. Whether H3K27 and H3K9
trimethylation exert overlapping roles under physiological cir-
cumstances remains an open question.
The unicellular eukaryote Paramecium tetraurelia shares the
highly conserved trimethylation of K9 and K27 on histone H3. In
this organism, two distinct types of nuclei with different functions
and genome architectures coexist in the same cytoplasm. The
diploid micronuclei (MIC, 2n) contain the germline genome that
is transmitted to sexual progeny after meiosis. A transcriptionally
active somatic macronucleus (MAC, 800n) contains a reduced
genome streamlined for gene expression. At each sexual cycle, the
parental MAC is lost, while new MICs and MACs, destined for
the progeny, develop from a copy of the diploid zygotic nucleus.
In the new developing MAC, the germline genome is endor-
eplicated to reach its final ploidy of ~800n and undergoes massive
programmed DNA elimination (for review23). At least 25% of the
~100Mb MIC genome is removed, including all repeated
sequences (transposable elements, tandem repeats…)24.
We have previously shown that the Enhancer-of-zeste-like
protein Ezl1 is essential for programmed DNA elimination and
viability of the sexual progeny25. Here, we provide evidence that,
Paramecium Ezl1, which exhibits significant sequence and
structural similarities with human EZH2, displays distinct enzy-
matic properties. The Ezl1 methyltransferase has a broader sub-
strate specificity, including histone H3K27 and K9, and
potentially secondary residues in vitro. Consistent with these
observations, a catalytic mutant of Ezl1 allows us to induce
extensive and simultaneous loss of H3K9me3 and H3K27me3
in vivo. By combining transcriptional and chromatin profiling, we
find that the H3K27me3 and H3K9me3 marks co-occur at
multiple families of transposable elements repressed by Ezl1. Our
work suggests that the ancient family of Enhancer-of-zeste pro-
teins may initially have evolved to silence mobile genetic
elements.
Results
Comparative homology modeling of the catalytic SET domain.
The SET domain of the Paramecium Ezl1 protein, ~130 amino
acids in length, shows 33% sequence identity with that of human
EZH2, the PRC2 catalytic subunit (Fig. 1a). Based on the recently
published crystal structure of human EZH2 in complex with
a histone H3K27M peptide and S-Adenosyl-L-homocysteine
(SAH)26, we performed homology modeling of the SET domain
of Ezl1 (Supplementary Fig. 1). It exhibits a pseudoknot-like
structure characteristic of the catalytic part of histone lysine
methyltransferases27. The methyl group from the cofactor S-
adenosylmethionine (SAM) is bound on one side of the pseu-
doknot, while the ε-amino group of the lysine residue to which it
is transferred is on the opposite side (Supplementary Fig. 1).
EZH2 and the modeled Ezl1 are highly conserved in structure.
The aromatic residues forming the lysine binding channel are
conserved in Ezl1 (Fig. 1b). The SAM binding pocket residues are
conserved or substituted either with different amino acids that do
not alter the hydrogen bond network between the amide
backbone and the cofactor, or with amino acids whose side
chains have similar properties (Fig. 1c). Interestingly, phenylala-
nine Phe-665 is substituted with a tyrosine residue (Tyr-502) in
Ezl1, likely providing an additional contact with the cofactor, as is
the case for methyltransferases that catalyze H3K9 methylation
(Fig. 1c)28.
A feature of the histone H3 substrate-binding site of human
EZH2 is the well-defined pocket accommodating the Arg-26
residue in the (−1) position. This residue makes a series of
hydrogen bonds to the complementary side chains of the I-SET
domain and is crucial for the recognition of the target lysine. Even
though the helix structure of the I-SET domain is maintained, the
amino acid side chain distribution is rather different in the
modeled Ezl1 structure. Indeed, polar residues (Asp-652 and Asp-
659) in EZH2 are substituted with two apolar residues (Met-489
and Trp-496) in Ezl1 (Fig. 1d). Consequently, the substrate
H3K27M is anchored in a different way. Only a few of the
described contacts with the H3K27M peptide are strictly
maintained in the modeled Ezl1 structure (Gln-648 (Asp-485 in
Ezl1), Leu-666, Asn-668 (Glu-505 in Ezl1), Ala-697, Tyr-726).
We hypothesize that additional interactions with the Asp-485,
Ser-488, Glu-492, and Glu-505 residues stabilize the arginine
residue in the (−1) position (Fig. 1d). Interestingly, the position
corresponding to Glu-505 contains a residue with similar
properties in the GLP and G9a histone K9 methyltransferases
(Asp-1145 and Asp-1088, respectively). Indeed, this aspartic acid
residue makes electrostatic interactions with the Arg-8 residue, in
the (−1) position of the histone K9 peptide26. In the modeled
Ezl1 structure, the hydrogen bond network appears to be
compatible with anchoring of an arginine residue at the (−1)
position for recognition of either lysine 27 or lysine 9 of the
histone H3 substrate.
Sequence comparison reveals a substitution of an alanine
(A677) in EZH2 with a glycine (G514) in Ezl1 (Fig. 1a). A glycine
at the equivalent position is also observed for the SET domain-
containing Dim-5 from Neurospora crassa (Fig. 1e), which has
been reported to trimethylate its H3K9 substrate29. Structural
comparison of the active sites of Ezl1 and Dim-5 shows that
residues surrounding the lysine channel are highly similar in Ezl1
and Dim-5 (Fig. 1e). The A677G substitution has been described
as a gain-of-function mutation in EZH2, found in lymphoma cell
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Fig. 1 Comparative sequence and homology modeling of the catalytic SET domain of Paramecium Ezl1 and human EZH2. a Sequence alignment of the SET
domains of Paramecium tetraurelia Ezl1 (PTET.51.1.G1740049) and human EZH2 (612–727; Q15910). The I-SET domain (648–674 in EZH2) is indicated.
Substrate and cofactor-binding residues as well as important residues for catalysis are highlighted in yellow, green, and red, respectively. Identical residues
are colored in gray and positively substituted residues in light gray. Positions A677 in EZH2 and H526 in Ezl1 are indicated by asterisks. b Conservation of
catalytic residues. Structural alignment of human EZH2 SET domain (cyan) (PDB ID: 5HYN) bound to the peptide inhibitor H3K27M (yellow) with modeled
Ezl1 (green). Superposition of the lysine binding channel shows the conserved aromatic residues: F724/565, Y726/567, F667/504, Y641/477 in EZH2 and
Ezl1, respectively. Note that tyrosine residue (Tyr-728) in EZH2 is replaced by an aspartic residue (Asp-569) in Ezl1, likely because of misalignment in the
post-SET domain. c Conservation of SAM-binding residues. Structural alignment of human EZH2 SET domain (cyan) bound to SAH cofactor (red) with
modeled Ezl1 (green). Hydrogen bonds are represented by red dashed lines. d Structural comparison of the SET domain of human EZH2 (cyan) bound to
H3K27M peptide (yellow) (left panel) with modeled Ezl1 (right panel). Substrate interacting residues are represented as sticks. Hydrogen bonds are
represented by red dashed lines. e Surface representation of the catalytic pockets of human EZH2 with H3K27M peptide (yellow) and SAH (red) (PDB ID:
5HYN), modeled Ezl1 and Neurospora crassa Dim-5 with H3K9 peptide (magenta) and SAH (red) (PDB ID: 1PEG)
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10648-5 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2710 | https://doi.org/10.1038/s41467-019-10648-5 | www.nature.com/naturecommunications 3
lines and primary tumors30. Interestingly, the modeled structure
predicts a larger catalytic pocket in Ezl1 than in EZH2 (Fig. 1e),
consistent with the increase of the dimensions of the lysine tunnel
reported for the EZH2 A677G mutant30. As observed for the
EZH2 mutant, it might confer a strong enzymatic activity to Ezl1
toward H3K27.
Thus, sequence and structural comparison of Ezl1 SET domain
with that of other histone methyltransferases reveals strong
similarities with human EZH2, consistent with previous phyloge-
netic analyses25. The most significant differences occur in the I-SET
region that contributes to the substrate-binding site, suggesting that
Ezl1 may have different substrate preferences from EZH2.
Ezl1 targets methylation of both K9 and K27 of histone H3. To
investigate the enzymatic activity of the Ezl1 protein, we obtained
Paramecium transformants expressing full-length, GFP-tagged
Ezl1, either wild-type or carrying a histidine-to-alanine sub-
stitution (H526A) in the highly conserved RXXNH cofactor-
binding motif within the SET domain (Fig. 1a, c), expected to
abolish catalytic activity3,31,32. Endogenous Ezl1 protein expres-
sion was specifically depleted through RNA interference while the
wild-type and mutant transgenes were designed to be RNAi-
resistant (see Methods). Both GFP fusion proteins were detected
at the expected molecular weight, ~97 kDa (Supplementary
Fig. 2). We enriched the GFP fusion proteins from nuclear
extracts isolated during MAC development by immunopurifica-
tion (GFP-Trap IP) (Supplementary Fig. 2). Enzymatic activity of
the IP was then assessed by monitoring the transfer of a radi-
olabeled methyl group to recombinant histones (Fig. 2a).
Reconstituted mammalian PRC2 core complex was used in par-
allel as a positive control. We found that, when incubated with
histone octamers or oligonucleosomes, GFP-Ezl1 immunopreci-
pitates transferred the labeled methyl group exclusively onto
histone H3 (Fig. 2a, lanes 3–5, Fig. 2b). PRC2 exhibited a similar
selectivity toward histone H3, as expected (Fig. 2a, lane 2). In
contrast, sharply reduced signals were detected with extracts from
the Ezl1H526A mutant (Fig. 2a, lanes 6–8), while no signal could
be detected in the mock control from non-transformed cells
(Supplementary Fig. 2). We conclude that the Ezl1 protein is
capable of catalyzing de novo methylation of histone H3 through
its catalytic SET domain.
Purified PRC2 is known to methylate histone H3 on K27 and
K9 in vitro, even though the activity towards K9 is low7–9. To
address the lysine specificity of the Ezl1 protein, we performed
in vitro methylation reactions on recombinant histone octamers
bearing lysine-to-alanine mutations on histone H3 either at K9
(K9A) or K27 (K27A), or both mutations on the same histone H3
tail (K9A/K27A). We used Xenopus histones, despite some
sequence divergence with Paramecium histones (Supplementary
Fig. 2), in order to directly compare Ezl1 activity with that of
PRC2. Reconstituted mammalian PRC2 core complex showed a
very strong preference for K27 as a methylation substrate, with
only a weak activity directed towards K9 (Fig. 2c, lanes 1–4), as
previously described7–9. In contrast, the methyltransferase
activity of GFP-Trap Ezl1 immunoprecipitates was moderately
reduced on both K9A and K27A single mutants, compared to
wild-type octamers (Fig. 2c, lanes 6–8). A stronger reduction was
observed on double K9A/K27A mutant octamers (Fig. 2c, lane 9),
approaching the low level observed for the GFP-Ezl1H526A
mutant on wild-type octamers (Fig. 2c, lane 10). The striking
difference in activity on the K27A and K9A/K27A mutant
octamers, which was not observed for PRC2, strongly suggests
that H3K9 is one of the principal substrates of Ezl1.
The 15% residual activity detected with the double K9A/K27A
H3 mutant may represent a contaminating activity in our
preparations or, alternatively, a weak activity of Ezl1 toward other
residues of H3. To distinguish between these possibilities, we
purified Ezl1 from soluble nuclear protein extracts using a
stringent FLAG-HA double-affinity immunopurification (see
Methods). In vitro methyltransferase activity was strongly
reduced on K9A/K27A double-mutant H3, confirming that
lysines 9 and 27 are the main targets of Ezl1 (Supplementary
Fig. 2). We then performed in vitro methylation reactions with
H3-H4 tetramers containing recombinant Paramecium H3,
instead of Xenopus H3, either wild-type or bearing lysine-to-
arginine mutations (K9R and K27R single mutants, and K9R/
K27R double mutant). Arginine substitution was chosen to
maintain the positive charge of the residues. Recapitulating our
above results, reduced methyltransferase activity was detected on
K9R/K27R double-mutant H3 compared to wild-type H3 or
single mutants (K9R and K27R) (Fig. 2d and Supplementary
Fig. 2), indicating that Ezl1 also targets both lysines 9 and 27 in its
conspecific H3 substrate. The H526A mutation severely compro-
mised the methyltransferase activity of Ezl1 in this setting as well
(Fig. 2d).
To investigate which lysine residue of Paramecium H3 is
methylated in an Ezl1-dependent manner, we performed
quantitative label-free mass spectrometry analysis. In vitro
methylation reactions were performed with tetramers containing
Paramecium histone H3 and with FLAG-HA double-affinity
purified Ezl1wt and Ezl1H526A, or with tetramers only as negative
controls. Under the assay conditions, Ezl1 catalyzes trimethyla-
tion of K9 and K27 (Fig. 2e, Table 1, and Supplementary Data 1).
We could detect the existence of other sites of methylation within
the N-terminal part of histone H3, in particular K23 (Supple-
mentary Data 1), but only the methylations on K9 and K27 are
significantly reduced in the catalytic Ezl1H526A mutant (Table 1,
Fig. 2e, and Supplementary Data 1).
Detection of methylation on other lysines provides an
explanation for the residual activity we detected when lysines 9
and 27 were mutated, either on Xenopus or Paramecium H3
(Fig. 2c, d and Supplementary Fig. 2). Using quantitative label-
free mass spectrometry analysis with K9R/K27R double-mutant
Paramecium H3, we indeed found that K23 is methylated in an
Ezl1-dependent manner when lysines 9 and 27 are no longer
substrates for methylation by the enzyme (Supplementary Data 1).
Altogether, our data support the hypothesis that lysines 9 and 27
are both major substrates of Ezl1, while K23 is a secondary site of
methylation whose in vivo relevance would require further
investigation.
Role of Ezl1 catalytic activity in vivo. To address the role of Ezl1
catalytic activity in vivo, we performed a genetic complementa-
tion assay by expressing the wild-type or mutant GFP-EZL1
transgenes in cells in which the endogenous EZL1 gene was
knocked down. The GFP fusion proteins were localized in the
zygotic MAC of the transformed cells in both control and EZL1
RNAi conditions, indicating that each RNAi-resistant transgene
produces a fusion protein with correct nuclear localization
(Fig. 3a, b)25. No toxicity was observed during vegetative growth
or following sexual events of transformed cells grown under
control conditions, indicating that the wild-type and mutant
GFP-EZL1H526A fusions have no dominant-negative effect.
Knockdown of the EZL1 gene results in loss of H3K27me3 and
H3K9me3 during development, blockage of programmed DNA
elimination and lethality of the sexual progeny25. To check
whether the wild-type and mutant transgenes are functional,
transformed cells were subjected to RNAi targeting the
endogenous EZL1 sequence during the self-fertilization sexual
process of autogamy (Fig. 3a). During development, H3K9me3
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and H3K27me3 deposition were assayed by immunostaining with
anti-H3K9me3 and anti-H3K27me3 antibodies, respectively.
Recovery of viable sexual progeny after sexual events was
measured by transferring individual autogamous cells to fresh
growth medium and letting them resume vegetative growth. In
non-injected cells, no H3K9me3 or H3K27me3 could be detected
in the developing MACs, and no viable progeny were obtained
upon EZL1 RNAi, indicating that the endogenous EZL1 gene is
efficiently silenced (Fig. 3b, c). Injection of the wild-type GFP-
EZL1 transgene restored both H3K9me3 and H3K27me3
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Fig. 2 Histone methyltransferase assay. Full-length wild-type GFP-Ezl1wt and mutant GFP-Ezl1H526A proteins were immunoprecipitated at 12 h after the
onset of sexual events (see Supplementary Fig. 2) from Paramecium transformed cells, in which endogenous Ezl1 protein expression was specifically
depleted through RNA interference, and used for in vitro histone methyltransferase reactions (a–c). aWild-type Xenopus recombinant histone octamers are
used as substrates and S-adenosyl-[methyl 3H]-methionine as methyl donor. Affinity-purified recombinant PRC2 complex is used as a positive control. The
same reactions with histone octamers only were performed as a negative control. Coomassie stain (CB, bottom panel) shows histones and the
autoradiograph (3H, top panel) indicates H3 histone methyltransferase activity. The graphs show relative quantification of histone methyltransferase
signals analyzed by scintillation counting after SDS-PAGE. b Histone methyltransferase activity on recombinant histone octamers (rOct) and on
oligonucleosomes (rNuc). c Substrate specificity. Histone methyltransferase assays were performed with recombinant histone octamers assembled with
wild-type H3 histones or with H3 histones bearing a point mutation on lysine 9 (K9A) or on lysine 27 (K27A) or on both (K9A/K27A) on the same histone
H3 tail. The same reaction without addition of histone octamers was performed as a negative control. For Ezl1wt and Ezl1H526A, the horizontal bars indicate
the mean of three biological replicates (independent nuclear extracts). Circles indicate the individual data points. d Full-length 3xFLAG-HA tagged Ezl1wt
and Ezl1H526A proteins were immunoprecipitated using a FLAG-HA double-affinity purification from Paramecium transformed cells, depleted for the
endogenous Ezl1 protein in the case of the mutant FLAG-HA-Ezl1H526A, and used in in vitro histone methyltransferase reactions (see Supplementary Fig. 2).
Histone methyltransferase assays were performed with recombinant histone tetramers assembled with wild-type H3 from Paramecium or with Paramecium
H3 histones bearing point mutations on both K9 and K27 (K9R/K27R) on the same histone tail. The horizontal bars indicate the mean of two or three
biological replicates (independent nuclear extracts) for Ezl1wt and Ezl1H526A, respectively. e Schematic representation of quantitative label-free mass
spectrometry analysis of Paramecium histone H3. See Table 1 and Supplementary Data 1. Owing to the insertion of one residue at position 14 in the
Paramecium H3 sequence (see Supplementary Fig. 2), positions in the Xenopus and Paramecium H3 sequences differs by one amino acid gap after that
position (Supplementary Fig. 2 and Supplementary Data 1). For simplicity, K24 and K28 in the Paramecium H3 sequence are referred to as K23 and K27 in
the schema and in the manuscript. Source data are provided as a Source Data file
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deposition and led to recovery of 95% viable progeny (Fig. 3b, c),
indicating that the GFP-EZL1 transgene fully complements the
EZL1 knockdown, and is therefore functional. In contrast, the
GFP-EZL1H526A mutant transgene was unable to complement an
EZL1 knockdown, as indicated by the complete absence of
H3K9me3 and H3K27me3 deposition and the absence of sexual
progeny bearing a functional zygotic MAC (Fig. 3b, c).
To analyze the effects of the transgenes on DNA elimination,
total genomic DNA was extracted at the end of MAC
development, when DNA elimination is normally complete, and
used to monitor a few representative loci by quantitative PCR
(Fig. 3d). As expected, all DNA elements tested were excised from
the new developing MACs in control RNAi, while the same DNA
elements were retained upon EZL1 RNAi in untransformed
clones (Fig. 3d). In the presence of the GFP-EZL1 complementing
transgene, DNA elimination levels returned to normal (Fig. 3d).
In contrast, expression of the GFP-EZL1H526A mutant transgene
failed to restore correct DNA elimination (Fig. 3d). Altogether,
these results show that the catalytic activity of Ezl1 is required
in vivo for the deposition of H3K9me3 and H3K27me3, for the
production of viable sexual progeny and for DNA elimination.
Transcriptional derepression of transposable elements. To
determine whether simultaneous loss of H3K9me3 and
H3K27me3 affects transcription, we performed paired-end RNA-
seq at different time-points during the life-cycle (Supplementary
Table 1). RNA samples were isolated during vegetative growth
(V) and during post-zygotic development (T0; T5; T10; T20; T35;
T50) of control and EZL1 RNAi cells. Comparison of steady-state
levels of poly-A RNAs between control and EZL1 RNAi was done
by mapping RNA-seq reads onto MAC and MIC reference gen-
omes and counting the fragments that map onto genes, trans-
posable elements (TE) and tandem repeats. Since cells enter
meiosis from a fixed point of the vegetative cell cycle33, which is
not synchronized in our cell cultures, there is an asynchrony of at
least 5 h in the time point samples. We therefore grouped sam-
ples, after normalization of the counts, using principal compo-
nent analysis (PCA), and treated the samples within groups
(Vegetative, Early, and Late; see Supplementary Fig. 3) as biolo-
gical replicates for differential gene expression analysis (see
Methods).
The P. tetraurelia genome encodes 41,533 genes (of which
40,640 are protein-coding genes)34, which account for about 56
Mb of sequence complexity (80% of the MAC genome is coding).
The germline MIC genome contains repeated sequences not
present in the MAC genome. Since our objective was to detect
transcripts both from genes and from repeated sequences, we
used a dual mapping strategy. To optimize specificity for gene
mapping, only uniquely mapping reads were considered. To
avoid underestimating expression of repeated elements, multiple
hits were allowed for mapping to repeated elements. These
consisted of tandem repeats (n= 1020, 0.43% of the MIC
assembly) and TE copies (n= 3129, 2.4% of the MIC assembly).
The TE copies were identified using a library of 61 manually
curated TE consensus sequences classified as TIR, LINE, Solo-
ORF, and SINE elements24. No autonomous transposons have
been identified in the genome and these TE copies mainly seem to
be highly degenerate.
To evaluate the differential expression of all genes, TEs and
tandem repeats, we first compared mean normalized fragment
counts across the life-cycle time course, for control and EZL1
RNAi samples. The results for the 45,682 genomic elements
(41,533 genes, 3129 TE copies, 1020 tandem repeats; see Methods
for details of the genome annotation) are presented in Fig. 4a.
Strikingly, TEs are almost exclusively expressed in EZL1 RNAi
samples and not in the control. In contrast, the expression of
tandem repeats and of genes is similar in EZL1 and control
samples. While 0.15% (N= 63) of the genes were differentially
expressed at the early time point, 5.8% (N= 2409) were either up-
or downregulated at the late time point (Supplementary Fig. 4
and Supplementary Data 2). Interestingly, differentially expressed
genes are enriched in genes known to be developmentally
regulated (Supplementary Table 2)34. Differentially expressed
genes that are upregulated in EZL1 knockdown correspond to
genes which, in control conditions, are expressed at the early time
point and repressed at the late time point (Supplementary Fig. 4).
This suggests that the Ezl1 protein functions in maintaining
transcriptional repression of developmental genes.
Closer inspection of TE copies shows that about half of all the
currently annotated TE copies in the genome become expressed
during zygotic MAC development upon EZL1 RNAi. The effect
increases during the time course and is most pronounced late in
development (Fig. 4b). As shown in the volcano plot representation
(Fig. 4c), 739 TE copies (24%) are differentially expressed (p < 0.05,
fold-change > 2). Strikingly, all the differentially expressed TE
copies undergo significant upregulation at the late time point,
ranging from 2 to > 500-fold-change in expression, with no case of
downregulation (Fig. 4c), a more dramatic effect than seen for the
upregulated differentially expressed genes (Supplementary Table 3).
While these 739 TE copies belong to all four of the major distinct
TE families that have been found in the genome, LINE copies
appear to be over-represented (Fig. 4d left panel).
To examine whether the burst of transcription observed from
bulk RNA profiling reflected a general trend within each TE
family, we measured the transcriptional output of individual
copies for each family. We note that each family of TEs includes
copies that are de-repressed by loss of H3K9me3 and H3K27me3,
Table 1 Quantitative label-free mass spectrometry analysis of Paramecium histone H3
Peptide sequence PTM position Sequence in sup.data 1 Ezl1H526A/ Ezl1wt ratio p-value
KSTAGNKKPTK Trimethyl (K9) 4 0.31 0.02
KSTAGNKKPTK Methyl (K9) 9 0.27 0.01
KSTAGNKKPTKHLATKAAR Methyl (K9) 12 0.72 0.03
KSTAGNKKPTKHLATKAAR Dimethyl (K9) 14 0.46 0.03
KSTAGNKKPTKHLATKAAR Trimethyl (K9) 15 0.26 0
KSTAGNKKPTKHLATKAAR Trimethyl (K9) and Methyl (K24) 16 0.3 0
KTAPAVGATGGLKKPHK Methyl (K28) 28 0.33 0.03
KTAPAVGATGGLKKPHK Trimethyl (K28) 30 0.36 0.01
KTAPAVGATGGLKKPHK Trimethyl (K28) 32 0.29 0.04
In vitro methylation reactions were performed with FLAG-HA double-affinity purified Ezl1wt and Ezl1H526A, or with tetramers only as negative controls, in three biological replicates. Histone H3 A
[Propionyl (N-term)]RTK[Propionyl (K)]QTAR peptide was used as internal reference (see Supplementary Data 1). The modified residues (in bold) as well as the post translation modification (PTM)
positions are indicated. Only significantly modified peptides are displayed (p-value < 0.05)
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as well as copies that are not affected (Fig. 4d right panel). To
examine whether this difference in silencing release correlates
with the time since the element was inserted into the genome, we
measured the identity of individual copies to the consensus
sequence as a proxy for their age. No correlation could be
observed between the putative age of the copy and its expression
level upon EZL1 RNAi (Fig. 4e, for LINE copies).
We wanted to rule out that the transcriptional upregulation we
observed did not simply reflect the retention of the transposable
elements in the zygotic MAC genome upon EZL1 RNAi. To this
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end, we performed a time-course quantitative reverse transcrip-
tion PCR (RT-qPCR) analysis of steady-state RNA levels upon
knockdown of the Pgm endonuclease, which, similarly to EZL1
knockdown, leads to complete retention of TE copies in the
zygotic MAC genome24,25,35. In contrast to EZL1 RNAi, we did
not detect transcriptional upregulation of transposable elements
upon PGM RNAi, as shown by RT-qPCR for three individual TEs
(Fig. 4f and Supplementary Table 4). These results strongly
suggest that retention of transposable elements in the MAC
genome is not sufficient to trigger their transcriptional upregula-
tion. Instead, upregulation of transposable element transcription
can be considered a specific consequence of Ezl1 loss. Altogether,
our analysis reveals that transposable elements undergo a global
release from silencing upon EZL1 knockdown.
H3K9me3 and H3K27me3 co-occur on transposable elements.
To determine whether the TEs that are transcriptionally upre-
gulated are targets of the Ezl1 methyltransferase, we devised a
chromatin immunoprecipitation (ChIP) procedure optimized for
developing Paramecium cells and measured local enrichment for
H3K9me3 and H3K27me3 in wild-type cells at an early stage of
development, followed by qPCR (ChIP-qPCR). ChIP-qPCR with
H3K4me3 antibody was used as a control. Twelve individual TEs
showed enriched occupancy of H3K27me3 and H3K9me3 com-
pared to genes, regardless of whether these copies were tran-
scriptionally upregulated upon EZL1 RNAi (Fig. 5a). As expected,
no enriched occupancy of H3K4me3 was detected for the TEs
compared to control reference genes (Fig. 5a). Similar experi-
ments performed in PGM knockdown cells showed the same
enrichment profiles as those observed in wild-type cells,
demonstrating that the Pgm endonuclease acts downstream of
H3K27me3 and H3K9me3 deposition (Fig. 5b top panel). This
result is in agreement with previous work showing that accu-
mulation of H3K27me3 and H3K9me3 in the developing zygotic
MAC is not altered upon PGM RNAi25. In contrast, a strong
reduction in H3K9me3 and H3K27me3 enrichment could be
observed on TEs upon EZL1 knockdown (Fig. 5b bottom panel).
Consistent with immunostaining experiments (Fig. 3 and ref. 25),
these data reveal a net loss of H3K9me3 and H3K27me3 on TEs
upon EZL1 RNAi.
The ChIP-qPCR analysis of individual loci indicates Ezl1-
dependent co-occurrence of H3K27me3 and H3K9me3 on the
same TE copies. To examine the chromatin states of transposable
elements more globally, we focused our analysis on the
distribution of H3K9me3, H3K27me3, and H3K4me3 marks by
chromatin immunoprecipitation followed by deep-sequencing
(ChIP-seq) in biological replicates upon PGM knockdown
(Supplementary Table 5). The use of PGM knockdown cells
allowed us to overcome the absence of synchrony in Paramecium
cell cultures and the loss of histone marks as development and
DNA elimination proceed. Indeed, PGM knockdown cells are
blocked at a late developmental stage, after H3K9me3 and
H3K27me3 are normally deposited and accumulated. ChIP-seq
reads were mapped (see Methods) on the 61 TE consensus
sequences24. Consistent with qPCR data, enrichment of
H3K27me3 and H3K9me3 marks with respect to the input was
observed on the TE consensus sequences, while there was no
enrichment of H3K4me3 (Fig. 5c). Furthermore, there is a
statistically significant correlation between the enrichment of
H3K27me3 and the enrichment of H3K9me3 (Supplementary
Fig. 5; Pearson correlation coefficient 0.923 and R2 linear
regression coefficient 0.853). Interestingly, all TE consensus
sequences showed enriched occupancy of H3K27me3 and
H3K9me3, regardless of whether the elements were transcrip-
tionally upregulated upon EZL1 knockdown or not (Fig. 5c and
Supplementary Fig. 6). Our data support the conclusion that loss
of H3K27me3 and H3K9me3 upon EZL1 RNAi coincides with
TE transcriptional derepression. However, releasing transcrip-
tional repression does not necessary result in transcription
activation. Altogether, our global analysis confirms and extends
our loci-oriented qPCR results and reveals that H3K9me3 and
H3K27me3 jointly decorate transposable elements.
Discussion
Our findings show that the Paramecium Enhancer-of-zeste Ezl1
protein, although similar to human EZH2 SET domain in
sequence and structure (Fig. 1), catalyzes methylation of both
lysine 9 and lysine 27 on histone H3 through its SET domain,
in vitro (Fig. 2) and in vivo (Fig. 3). EZL1 knockdown results in
simultaneous loss of H3K9me3 and H3K27me3 and massive
transcriptional upregulation of transposable elements, with only a
minor effect on protein-coding gene expression (Fig. 4 and
Supplementary Fig. 4). Consistently, we also demonstrate that
H3K9me3 and H3K27me3 co-occur on transposable elements in
an Ezl1-dependent manner (Fig. 5). These observations reveal
Fig. 3 In vivo genetic complementation assay. a Life-cycle of Paramecium. Each cell contains a macronucleus (MAC) and two micronuclei (MICs), both of
which divide and segregate to daughter cells during vegetative growth. Starvation triggers MIC meiosis, and one of the meiotic products divides mitotically
to form two haploid nuclei. During autogamy, a self-fertilization process, the two haploid nuclei will fuse to produce the zygotic nucleus (karyogamy), which
then divides twice to form two new MACs and two MICs. During development of the new MAC, the MIC genome undergoes massive programmed DNA
elimination. Upon nutrient supply, post-autogamous cells will undergo the first cellular division and produce sexual progeny that will resume vegetative
growth. The parental MAC is degraded into fragments that will eventually be diluted through cell divisions. b H3K27me3 and H3K9me3 immunostaining of
non-injected cells (NI), and of cells transformed with GFP-EZL1wt or GFP-EZL1H526A RNAi-resistant transgenes upon control or EZL1 RNAi during MAC
development, at ~25 h after the onset of sexual events. The non-essential ND7 gene was used as RNAi control. Representative images (percentage in cell
population is indicated, n≥ 100) are displayed. Overlay of Z-projections of magnified views of H3K27me3- or H3K9me3-specific antibodies (in cyan), of
GFP (in green) and Hoechst (in red) are presented. Dashed white circles indicate the new developing MACs. The other Hoechst-stained nuclei are
fragments from the old vegetative MAC. In control cells, H3K27me3 is detected in the fragments from the old vegetative MAC, while both H3K9me3 and
H3K27me3 are detected in the new developing MACs. The scale bar is 10 μm. c Production of sexual progeny following control (CTL) or EZL1 gene
silencing in non-injected (NI) cells, GFP-EZL1wt and GFP-EZL1H526A transformed cells. Cells were starved in each medium to induce autogamy and, following
3–4 days of starvation, post-autogamous cells were transferred individually to standard growth medium to assess the ability of sexual progeny to resume
vegetative growth. The total number of cells analyzed for each RNAi and the number of independent experiments (in parenthesis) are indicated. Transgene
copy number per haploid genome (see Methods): 6.9 (n= 30) and 76.4 (n= 58) for GFP-EZL1wt, 3.4 (n= 30), and 5.8 (n= 60) for GFP-EZL1H526A.
d Quantification of the relative copy number of individual TEs (Anchois; RT12275; RT25765; RT31010; RT42890) as measured by qPCR from total genomic
DNA extracted at the end of MAC development from non-injected (NI), GFP-EZL1wt and GFP-EZL1H526A transformed cells after control (CTL) or EZL1 RNAi.
Values were normalized to a MIC-specific, single copy genomic locus. The horizontal bars represent mean of biological replicates. Circles indicate the
individual data points. Source data are provided as a Source Data file
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experiment. Data represent the mean expression from two biological replicates for PGM RNAi. Data source are provided as a Source Data file
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Fig. 5 H3K27me3 and H3K9me3 mark the same transposable element copies in an Ezl1-dependent manner. a H3K9me3, H3K27me3, and H3K4me3
enrichment at individual copies from different TE families at an early stage of development (at 10 h after the onset of sexual events) in wild-type cells as
measured by ChIP-qPCR. Quantitative data are expressed as the percentage of ChIP over Input. ACTIN, GAPDH, EE PPASE, ST PPASE, ST KINASE, and
HELICASE are control genes (Supplementary Table 4 for accession numbers and primers). According to the RNA-seq analysis, Anchois (TIR), RT31010;
RT42890; RT50144; RT48784–1; RT48639–1; RT48639–2 (LINEs) are significantly upregulated upon EZL1 RNAi, whereas RT25765; RT12275; RT32989;
RT43773; RT48784–1 (LINEs) are not. Circles (black for genes; white for TEs) indicate the individual data points. Horizontal bars represent the mean of
biological replicates. b H3K9me3, H3K27me3, and H3K4me3 enrichment at the same individual TE copies at a late stage of development (50 h after the
onset of sexual events) upon PGM (top panel) or EZL1 (bottom panel) RNAi as measured by ChIP-qPCR. Data are represented as in a. c Heatmap of
H3K27me3, H3K9me3, and H3K4me3 enrichment for 61 TE families determined by ChIP-seq of two biological replicates. Colors represent the fold-change
(log2) in a given TE family for each histone mark relative to input. Source data are provided as a Source Data file
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that an Enhancer-of-zeste protein mediates transcriptional
silencing of transposable elements.
The SET domains of Paramecium Ezl1 and human EZH2
exhibit significant structural similarities (Fig. 1), yet Ezl1 displays
distinct enzymatic properties. Although we cannot formally
exclude the possibility that the effect of in vivo Ezl1 depletion on
the methylation of a specific lysine is indirect, we believe that the
most parsimonious explanation, given the body of experimental
evidence obtained in this study, is that H3K9 and H3K27 are both
recognized as substrates by the Paramecium Ezl1 protein. Indeed,
we show that: (i) Ezl1 purified from Paramecium nuclear extracts
is able to catalyze in vitro methylation of Xenopus and Para-
mecium histone H3 (Fig. 2 and Supplementary Fig. 2); (ii) this
activity is severely compromised in the Ezl1H526A mutant, which
carries a substitution in the highly conserved RXXNH cofactor-
binding motif within the catalytic SET domain (Fig. 2 and Sup-
plementary Fig. 2); (iii) K9 and K27 on Paramecium H3 are
methylated in Ezl1-dependent manner (Fig. 2; Table 1; Supple-
mentary Fig. 2; and Supplementary Data 1); (iv) Ezl1 in vitro
methyltransferase activity is reduced using K9/27 double-mutant
H3 compared to wild-type H3 or single mutants (Fig. 2 and
Supplementary Fig. 2). (v) Ezl1 catalytic activity is necessary
in vivo for the deposition of H3K9me3 and H3K27me3 (Fig. 3).
We noted that K23 is methylated in vitro in an Ezl1-dependent
manner when lysines 9 and 27 are mutated and no longer sub-
strates for methylation by the enzyme (Fig. 2 and Supplementary
Data 1). Future work will be needed to determine whether this or
additional methylations occur in an Ezl1-dependent manner
in vivo and whether they are biologically significant.
In vitro methyltransferase assays performed with purified
PRC2 have shown activity on both K9 and K27 of the histone H3
tail, albeit with an overwhelming preference for K27 (Fig. 2c and
refs. 7–9). In vivo, however, H3K9 methylation levels are not
affected in the absence of PRC26,36,37. The amino acid sequence
of the H3 tail is highly conserved and the H3K9 and H3K27
lysines are typically embedded within a similar ARKS peptide
sequence, making plausible the existence of common modifying
enzymes. Interestingly, KDM7 is a dual demethylase with the
ability to mediate the direct removal of methyl groups from both
H3K9 and H3K2738.
Altogether, our results show that Enhancer-of-zeste protein
Ezl1 displays a broader specificity than EZH2, with both K9 and
K27 on histone H3 as its main targets. In the future, it will be
interesting to determine what properties, of Ezl1 itself or its
associated complex subunits, confer broader specificity to this
Enhancer-of-zeste homolog.
Our ChIP experiments show co-occurrence of H3K9me3 and
H3K27me3 on the same TE copies. Loss of these marks upon
EZL1 RNAi coincides with TE transcriptional derepression.
Altogether, our data demonstrate the function of an Enhancer-
of-zeste protein in silencing genomic parasites such as trans-
posable elements. This Ezl1-dependent silencing mechanism is
broad and does not discriminate among the elements that it
silences. Indeed, the genome-wide relaxation observed upon
Ezl1 depletion involved all TE families, DNA transposons as
well as non-LTR retrotransposons, but not all copies within a
given family (Fig. 4). No correlation could be observed between
the age of the copy and its expression level upon EZL1 RNAi,
indicating that other, unidentified factors may explain this
difference. In contrast to our findings, previous work has
uncovered only isolated examples of Enhancer-of-zeste invol-
vement in controlling transposable and repetitive elements.
The PRC2 pathway has been reported to repress the expression
of two types of endogenous retroviruses in mouse embryonic
cells39. A different mechanism, in which the retinoblastoma
(Rb) protein utilizes an interaction with E2F1 to recruit
Enhancer-of-zeste-homolog 2 (EZH2) and establish
H3K27me3, silences expression of genomic repeats, such as
tandem repeats and retrotransposons, in mouse embryonic
fibroblasts. However, the upregulation of repeat sequences in
Rb mutants is rather weak and appears quite variable40. In the
unicellular green alga Chlamydomonas reinhardtii, inactivation
of an Enhancer-of-zeste homolog was shown to derepress the
expression of one retrotransposon, but the effect was not ana-
lyzed genome-wide41. The scale of TE derepression we observe
in Paramecium is remarkable: ~24% of the known TE copies
show a 2 to > 500-fold-change in expression compared to
control conditions. Such a massive level of derepression can be
explained, at least in part, by the fact that germline TE copies
are retained in the zygotic MAC genome upon H3K9me3 and
H3K27me3 loss and are highly endoreplicated during devel-
opment. This peculiarity of the biological system may thus
allow detection of TE relaxation at the whole-genome scale, and
offers an ideal model organism to further elucidate the
underlying mechanisms.
How the Ezl1 protein is recruited to its target sites remains to
be discovered. Previous work has shown that developmental-
stage-specific small RNAs (sRNAs) produced by the Dicer-like
proteins Dcl2 and Dcl3 are required for the deposition of
H3K9me3 and H3K27me3 in the developing zygotic MAC25. We
therefore propose that Dcl2/Dcl3-dependent sRNAs guide the
deposition of H3K9me3 and H3K27me3 to homologous loci,
which include TEs, in the developing zygotic MAC. The
H3K27me3 and H3K9me3 marks would then promote the
recruitment (or activation) of the Pgm endonuclease, leading to
the elimination of the marked chromatin23,42.
Heterochromatin formation via sRNA-dependent mechan-
isms has been observed in a variety of organisms43. For
instance, the RNAi machinery directs silencing at repetitive
centromeric regions in S. pombe in a process that involves
H3K9 methylation. Nuclear pathways involving sRNAs and
H3K9 methylation also repress repetitive elements and genes in
different eukaryotes, including Arabidopsis, Drosophila, mice,
worms, and humans43. Transcriptional silencing of repetitive
genomic elements is thus typically ensured by H3K9me3 and is
associated with constitutive heterochromatin. There are striking
similarities between these sRNA-dependent heterochromatin
formation mechanisms and sRNA-directed DNA elimination,
except that, in Paramecium, it goes a step further with the
physical elimination of sequences that are associated with
H3K9me3 and H3K27me3.
From an evolutionary point of view, one important implication
of our work is that the primary function of the ancient family of
Enhancer-of-zeste proteins may originally have been to silence
transposable elements. We propose an evolutionary scenario
whereby ancestral Enhancer-of-zeste proteins, like the Para-
mecium Ezl1, catalyzed both H3K9me3 and H3K27me3, and
played a role in the silencing of intragenomic parasites, such as
transposable elements, through the concerted action of both of
these histone marks. Enzymes dedicated to the catalysis of
H3K9me3 may later have been co-opted to silence genomic
repeats and Enhancer-of-zeste enzymes may then have evolved
for lineage-specific roles, like the regulation of genes involved in
development.
In favor of this hypothesis, PRC2 components are widespread
in the major supergroups of eukaryotes (Opisthokonta (animals
and fungi), Archaeplastida (red algae, green algae and plants),
and Chromalveolata (ciliates such as Tetrahymena and Para-
mecium)), which strongly supports the idea that PRC2 subunits
emerged in an ancestral unicellular eukaryote41. The phylogenetic
distribution of H3K9me3-specific enzymes, the Su(var)3–9
homologs, seems instead to be restricted to unikonts (animals,
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fungi, and Amoebozoa) and plants, according to ref. 44. Yet the
existence of H3K9me3 appears to predate the appearance of
these K9-specific methyltransferases, based on observations made
in Chlamydomas41, diatoms45, and ciliates25,46,47. In the diatom
P. tricornutum, H3K27me3 was shown to occur on transposable
elements together with H3K9me345, in agreement with the
hypothesis of an evolutionarily ancient function for a dual
H3K27/H3K9 methyltransferase in transcriptional repression
of TEs.
Even though eukaryotic genomes are often described as con-
taining two types of heterochromatin that serve largely distinct
functions, there are examples in animals and fungi of an interplay
between H3K27me3 and H3K9me3. For instance, H3K27me3
and H3K9me3 overlap at a subset of developmental genes in
some cell types15–17, suggesting that H3K27me3 and H3K9me3
cooperate to maintain gene silencing48. Similarly, domains where
H3K9me3 and H3K27me3 co-occur have also been reported in
the nematode Caenorhabditis elegans11, and both marks are
required for silencing of heterochromatic transgenes49. There are
also some hints that Polycomb systems may interact with con-
stitutive heterochromatin associated with H3K9me3, both in
normal and mutant contexts. In the early mouse embryo,
H3K27me2/3 accumulate at paternal pericentromeric hetero-
chromatin after fertilization50,51. Perturbation of constitutive
heterochromatin, through loss of H3K9me3 in pericentric het-
erochromatin in SUV39H knock-out mouse embryonic stem
cells, is associated with new domains of H3K27me3 in patterns
resembling those typical of H3K9me313. In the filamentous fun-
gus N. crassa, disruption of H3K9me3 causes redistribution of
H3K27me2/3 to regions of constitutive heterochromatin,
including centromeres52. Meanwhile, in the human fungal
pathogen C. neoformans, H3K27me3 is lost from the telomeric
regions it normally occupies and becomes redistributed to cen-
tromeric regions when a chromodomain protein that is part of
the PRC2 complex in this organism is mutated53. Collectively,
these examples reveal that H3K27me3 can relocate under some
circumstances, resulting in cohabitation of both H3K9me3 and
H3K27me3 histone marks in the same genomic regions. This
suggests a widespread functional redundancy between
H3K27me3 and H3K9me3 pathways. Our current findings pro-
vide an ideal foundation for determining the extent of this
redundancy and untangling its mechanisms.
Methods
Paramecium strains, cultivation, and autogamy. Unless otherwise stated, all
experiments were carried out with the entirely homozygous strain 51 of P. tetra-
urelia. Cells were grown in wheat grass powder (WGP) (Pines International)
infusion medium bacterized the day before use with Klebsiella pneumoniae, unless
otherwise stated, and supplemented with 0.8 mg/mL β-sitosterol (Merck). Culti-
vation and autogamy were carried out at 27 °C as described54,55.
Injection of tagged EZL1 transgenes. The previously published GFP-EZL1
transgene25 was used to generate RNAi-resistant derivatives. The original PstI-
HpaI restriction fragment of the EZL1 coding sequence that comprises the RNAi
target region (EZL1-1 in ref. 25) was replaced by a synthetic DNA sequence
(Eurofins Genomics) designed to maximize nucleotide sequence divergence with
the endogenous genomic locus without modifying the amino acid sequence of the
encoded Ezl1 protein. Within this synthetic DNA fragment, SpeI and BlpI
restriction sites were introduced at positions 1393 and 1685 of the EZL1 coding
sequence (GSPATG00037872001/PTET.51.1.G1740049) on either side of the
highly conserved RXXNH motif within the SET domain (position 1636 to 1650).
To generate the GFP-EZL1H526A mutant transgene, the SpeI-BlpI fragment was
replaced by a synthetic DNA fragment (Eurofins Genomics), in which the
histidine-coding triplet AGG from nucleotide 1648 to 1650 was replaced by GCT.
The resulting missense mutation results in a histidine to alanine substitution in
position 526 of the Ezl1 protein (H526) within the RXXNH motif3,31,32. Plasmids
expressing FLAG-HA-EZL1 and FLAG-HA-EZL1H526A are the same as the GFP-
EZL1 plasmids, except that a 3xFLAG (DYKDDDDK-DYKDDDDK-DYKDD
DDK)—HA (YPYDVPDYA) tag, that was codon-optimized for the P. tetraurelia
genetic code, is fused to EZL1 in place of GFP. Plasmids were linearized with XmnI
and microinjected into the MAC of vegetative 51 cells.
For genetic complementation experiments, two transformed clones for each
RNAi-resistant transgene (GFP-EZL1 or GFP-EZL1H526A) were chosen. The
relative copy number of the transgenes was measured by qPCR from total genomic
DNA extracted from vegetative cells and values were normalized to an endogenous
gene (PTET.51.1.G1740048) (transgene copy number per haploid genome). No
lethality was observed in the post-autogamous progeny of injected cells, indicating
that the GFP-Ezl1 and GFP-Ezl1H526A fusion proteins did not interfere with
normal progression of autogamy in normal conditions (Fig. 3).
Gene silencing experiments. Plasmids used for T7Pol-driven dsRNA production
in silencing experiments were those previously described25: ND7, ICL7a, EZL1-1,
and PGM-1. Preparation of silencing medium and RNAi during autogamy were
performed as described in ref. 25. Lethality of post-autogamous cells after RNAi was
assessed by transferring 30–60 individual post-autogamous cells to standard
growth medium. Cells with a functional new MAC were identified as normally
growing survivors unable to undergo a novel round of autogamy if starved after ∼8
divisions.
Antibodies, dot-blot, and competition assays. Polyclonal rabbit anti-GFP
(1:5000, Abcam, ab290) and monoclonal mouse anti-FLAG (1:1000, ThermoFisher
Scientific, MA1–91878) antibodies were used for western blot analysis. Rabbit
monoclonal anti-H3K4me3 antibodies were purchased from Merck Millipore
(Billerica, MA, USA; catalog number #04–745, batch #2739249). Considering the
fact that Paramecium histone H3 displays some amino acid differences with respect
to mammalian histone H3 (Supplementary Fig. 2), polyclonal rabbit antibodies
were raised to peptide sequences of the Paramecium H3 protein with Eurogentec
(Seraing, Belgium): MSRDIQLARRIRGERF for anti-H3, KQTARK(me3)STAGNK
for anti-H3K9me3 and TKAARK(me3)TAP for anti-H3K27me3 antibodies. Spe-
cificity of the custom made anti-modification antibodies was validated by dot-blot
and competition assays (Supplementary Fig. 7).
Indirect immunofluorescence. Cells were fixed as previously described25 with
some modifications. Briefly, cells were collected in centrifuge tubes and fixed for 30
min in Solution I (10 mM EGTA, 25 mM HEPES, 2 mM MgCl2, 60 mM PIPES pH
6.9 (PHEM 1 × ); 1% formaldehyde (Sigma-Aldrich), 2.5% Triton X-100, 4%
Sucrose), and for 10 min in solution II (PHEM 1 × , 4 % formaldehyde, 1.2% Triton
X-100, 4% Sucrose). Following blocking in 3% bovine serum albumin-
supplemented Tris buffered saline-Tween 20 0.1 % (TBST) for 10 min, fixed cells
were incubated overnight at room temperature with primary antibodies as follows:
rabbit anti-H3K9me3 (1:200), rabbit anti-H3K27me3 (1:1000). After two washes in
TBST, cells were labeled with Alexa Fluor 568-conjugated goat anti-rabbit IgG
(Invitrogen, catalog number #A-11036) at 1:500 for 1 h, stained with 1 μg/mL
Hoechst for 5–10 min, washed in TBST and finally mounted in Citifluor AF2
glycerol solution (Citifluor Ltd, London). Images were acquired using a Zeiss LSM
780 laser-scanning confocal microscope and a Plan-Apochromat 63 × /1.40 oil DIC
M27 objective. Z-series were performed with Z-steps of 0.35 μm.
DNA extraction and real-time quantitative PCR. DNA samples were typically
extracted from 200–400 mL cultures of exponentially growing cells at 1000 cells/mL
or of autogamous cells at 2000–4000 cells/mL24. DNA concentration was quanti-
fied with the Qubit dsDNA BR Assay Kit (Thermo Fisher Scientific) and stored at
4 °C. Real-time quantitative PCR was performed using the ABsolute QPCR SYBR
Green Capillary Mix (Thermo Fisher Scientific) on the LightCycler 1.5 thermal
cycling system (Roche). DNA amount of individual TEs was normalized to a MIC-
specific, single copy genomic locus (IES 51A1835). Primers are listed in Supple-
mentary Table 4.
RNA extraction, RT-qPCR, and RNA sequencing. For total RNA extraction,
200–400 mL cultures of exponentially growing cells at 1000 cells/mL or of auto-
gamous cells at 2000–4000 cells/mL were centrifuged and flash-frozen in liquid
nitrogen prior to TRIzol (Invitrogen) treatment, modified by the addition of glass
beads for the initial lysis step. RNA concentration was quantified with the Qubit
RNA HS Assay Kit (Thermo Fisher Scientific).
RNA samples were reverse-transcribed with RevertAid H Minus Reverse
Transcriptase (Thermo Fisher Scientific) using random primers (Thermo Fisher
Scientific) according to the manufacturer’s instructions. Real-time quantitative
PCR was performed using the ABsolute QPCR SYBR Green Capillary Mix
(Thermo Fisher Scientific) on the LightCycler 1.5 thermal cycling system (Roche).
Expression levels were normalized to the GAPDH gene and to the T0
developmental time point within each condition with the ΔΔCt method. Primers
are listed in Supplementary Table 4.
For RNA-seq libraries, poly-A+ RNA was extracted at different time-points
during autogamy (Veg; T0; T5; T10; T20; T35; T50) from ICL7 and EZL1 RNAi
samples described in ref. 25 using the FastTrack MAG mRNA isolation kit (Thermo
Fisher Scientific) following the manufacturer’s instructions. Strand-oriented
Illumina libraries were made as described in ref. 34. HiSeq paired-end sequencing
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was performed on the samples, yielding at least 2 × 30 million reads, 100 nt in
length, for each of the samples (Supplementary Table 1).
Chromatin immunoprecipitation. In all, 5–8 × 106 autogamous cells were col-
lected by centrifugation and cross-linked with 1% methanol-free formaldehyde
(Thermo Fisher Scientific) PHEM 1 × (10 mM EGTA, 25 mM HEPES, 2 mM
MgCl2, 60 mM PIPES pH 6.9) for 10 min at room temperature. After quenching
with 0.125 M glycine, cells were washed and pelleted. Cells were then lysed with a
Potter-Elvehjem homogenizer in lysis buffer (0.25 M sucrose, 10 mM Tris pH 6.8,
10 mM MgCl2, 0.2% Nonidet P-40, 1 mM PMSF (Sigma-Aldrich), 4 mM benza-
midine (Sigma-Aldrich); 1x Complete EDTA-free Protease Inhibitor Cocktail
tablets (Roche)). Following the addition of 2.5 volumes of washing solution (0.25 M
sucrose, 10 mM MgCl2, 10 mM Tris pH 7.4, 1 mM PMSF (Sigma-Aldrich), 4 mM
benzamidine (Sigma-Aldrich), 1x Complete EDTA-free Protease Inhibitor Cocktail
tablets (Roche)), the nuclei-containing pellet was collected by centrifugation and
resuspended at 2 × 106 cells/mL in RIPA buffer without sodium dodecyl sulfate
(SDS) (50 mM Tris pH 8, 150 mM NaCl, 10 mM EDTA, 1% Nonidet P-40, 0.5%,
sodium deoxycholate, 1 mM PMSF (Sigma-Aldrich), 4 mM benzamidine (Sigma-
Aldrich), 1x Complete EDTA-free Protease Inhibitor Cocktail tablets (Roche)),
flash-freezed in liquid nitrogen as 200 μL aliquots and stored at −80 °C. After
addition of SDS to a final concentration of 1%, chromatin was sonicated with
Bioruptor (Diagenode) to reach a fragment size of 200–500 bp. DNA concentration
was quantified with the Qubit dsDNA BR Assay Kit (Thermo Fisher Scientific).
Chromatin corresponding to 13 μg of DNA was diluted 10-fold in RIPA buffer
without SDS complemented with protease inhibitors and incubated overnight at
4 °C with 4 μg of H3K9me3 or H3K27me3 antibodies or with 4 μL of the H3K4me3
monoclonal antibody. As input control, 10% of sheared chromatin was taken aside.
Antibody-bound chromatin was recovered after incubation for ~7 h at 4 °C with
Magna ChIP Protein A+G Magnetic Beads (16–663, Millipore). Beads were
washed twice with Low salt buffer (0.1% SDS, 1% Triton, 2 mM EDTA, 20 mM Tris
pH 8, 150 mM NaCl), twice with High salt buffer (0.1% SDS, 1% Triton, 2 mM
EDTA, 20 mM Tris pH 8, 500 mM NaCl), once with LiCl wash buffer (10 mM Tris
pH 8.0, 1% Na-deoxycholate, 1% Nonidet P- 40, 250 mM LiCl, 1 mM EDTA) and
once with TE 50mM NaCl (50 mM Tris pH 8.0, 10 mM EDTA, 50 mM NaCl).
Chromatin was eluted with TE 1% SDS (50 mM Tris pH 8.0, 10 mM EDTA, 1%
SDS) at 65 °C for 45 min. ChIP-enriched samples and inputs were then reverse-
cross-linked at 65 °C overnight and treated with RNase A and proteinase K. DNA
was extracted with phenol, precipitated with glycogen in sodium acetate and
ethanol and resuspended in deionized distilled water. Enrichment compared to
input was analyzed by qPCR. qPCR was performed using the ABsolute QPCR
SYBR Green Capillary Mix (Thermo Fisher Scientific) on the LightCycler 1.5
thermal cycling system (Roche). qPCR primers are listed in Supplementary Table 4.
For RT48784-1 and RT48784-2, sequencing of PCR products confirmed that each
set of primers specifically amplified a single TE copy. Approximately 5 ng of DNA
were used for ChIP-seq library preparation. Truseq Illumina adapters were ligated
and the libraries have been sized to 200–500 pb using a Beckman SPRI-TE auto-
mate and a spriworks fragment library kit (Beckman coulter). Ligation were
amplified (15 cycles) with Kapa Hifi DNA polymerase (Kapa Biosystem). Libraries
were pooled and sequenced on an Illumina NextSeq500 instrument, according to
the manufacturer recommendations, in a Paired-End 2 × 80 pb run (NextSeq500/
550 Mid Output Kit v2 (150 cycles)).
Nuclear extraction and immunoprecipitation. To prepare nuclear extracts, auto-
gamous cells were lysed with a Potter-Elvehjem homogenizer in lysis buffer (10mM
Tris pH 6.8, 10 mMMgCl2, 0.2% Nonidet P-40, 1 mM PMSF (Sigma-Aldrich), 4 mM
benzamidine (Sigma-Aldrich), 1x Complete EDTA-free Protease Inhibitor Cocktail
tablets (Roche)). Following the addition of 2.5 volumes of washing solution (0.25M
sucrose, 10mM MgCl2, 10mM Tris pH 7.4, 1 mM PMSF (Sigma-Aldrich), 4 mM
benzamidine (Sigma-Aldrich), 1x Complete EDTA-free Protease Inhibitor Cocktail
tablets (Roche)), the nuclei-containing pellet was collected by centrifugation and
incubated in 1 volume of nuclear extraction buffer 2 × (100mM Hepes (pH 7.8),
100mM KCl, 600mM NaCl, 0.2 mM EDTA, 20% Glycerol, 2 mM DTT, 0.02%
Nonidet P-40, 2 mM PMSF, 2x Complete EDTA-free Protease Inhibitor Cocktail
tablets (Roche)) at 4 °C overnight. The salt-extractable fraction was recovered fol-
lowing centrifugation at 10,000 × g at 4 °C for 3 min. Protein concentration was
quantified with the Qubit Protein Assay Kit (Thermo Fisher Scientific).
For immunoprecipitations of GFP fusion proteins, 400 μg of nuclear protein
extracts at 12 h after the onset of sexual events obtained from Paramecium
transformed cells, in which endogenous Ezl1 protein expression was specifically
depleted through RNA interference, was used for GFP-Trap immunoprecipitation.
Briefly, nuclear extracts were incubated for 1 h at 4 °C with GFP-Trap_M magnetic
beads (Chromotek). Beads were washed three times in Wash Buffer (10 mM Tris/
Cl pH 7.5, 600 mM NaCl, 0.5 mM EDTA, 0.01% Nonidet P-40).
For tandem affinity immunoprecipitation of 3xFLAG-HA tagged proteins, 1 mg
of nuclear extracts was incubated overnight at 4 °C with anti-FLAG M2 magnetic
beads (M8823, Sigma). Beads were washed five times with TEGN buffer (20 mM
Tris pH 8, 0.1 mM EDTA, 10% Glycerol, 300 mM NaCl, 0.01% NP40). After
elution with the FLAG peptide (F4799, Sigma), the eluate was further affinity-
purified on anti-HA antibody-conjugated agarose (A2095, Sigma) overnight at 4 °C
and eluted with the HA peptide (I2149, Sigma) overnight at 4 °C.
Histone methyltransferase assays. GFP-Trap IP beads were resuspended in
50–100 μL of HMT buffer 1 × (50 mM Tris-HCl pH 8.5, 2.5 mM MgCl2) and ali-
quots of 1 to 5 µL were used. For histone methyltransferase assays with tandem
affinity purified FLAG-HA IP, 2 µL of the final eluate was used. Beads (or eluates)
were incubated with either recombinant Xenopus histone octamers (rOct, 1 µg),
reconstituted oligonucleosomes (2 µg), prepared as previously described56, or
recombinant Paramecium histone H3/Xenopus histone H4 tetramers (1 µg) in the
presence of 4 mM DTT and 2 µM 3H-labeled S-adenosylmethionine, in a volume of
25 µL per reaction, for 30 min at 30 °C. Paramecium histone H3 (H3P157), encoded
by a synthetic gene (Eurofins Genomics) adapted to the universal genetic code, was
expressed and purified from E. coli then used to assemble histone tetramers by salt
dialysis as described56. Reactions were stopped by addition of sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and analyzed
by SDS-PAGE, transfer to polyvinylidene difluoride membranes, Coomassie
staining, and autoradiography. Affinity-purified, reconstituted mammalian PRC2
core complex (EED, EZH2, SUZ12 and RbAp48) was prepared as previously
described58 and used as a positive control.
Quantitative label-free mass spectrometry. Full-length 3xFLAG-HA-tagged
Ezl1wt and the catalytic mutant Ezl1H526A were immunoprecipitated using a
FLAG-HA double-affinity purification from nuclear extracts prepared 12 h after
the onset of sexual events in transformed Paramecium cells, depleted for the
endogenous Ezl1 protein in the case of FLAG-HA-Ezl1H526A. In vitro histone
methyltransferase assays were performed with immunoprecipitated Ezl1wt and
Ezl1H526A proteins from three biological replicates (independent nuclear extracts)
and with recombinant histone tetramers (2 µg per reaction), assembled with wild-
type Paramecium H3 (H3P157) histones as substrates and 30 µM S-
adenosylmethionine as methyl donor, in the presence of 4 mM DTT, in a volume of
25 µL per reaction, for 1 h at 30 °C. The same reactions with histone tetramers only
were performed in triplicate as negative controls. The reaction products were
separated on a 15% SDS-PAGE gel and stained with colloidal coomassie blue
(LabSafe Gel Blue™, AGRO-BIO) without methanol and acetic acid.
The band corresponding to histone H3 was excised for each sample and
washed, and proteins were reduced with 10 mM DTT prior to alkylation with 55
mM iodoacetamide. After washing and shrinking of the gel pieces with 100%
acetonitrile, propionylation was performed. The shrink gel bands were chemically
derivatized by treatment with propionic anhydride before and after trypsin
digestion. Briefly, this reaction mixture was created using ¾ propionyl anhydride
(Sigma-Aldrich) and ¼ isopropanol. Twenty microliters of propionylation reagent
were added to each band adjusted with ammonium hydroxide to pH 8 and allowed
to react at 51 °C for 20 min (two times) and reduced to dryness using a SpeedVac
concentrator for removal of reaction remnants before trypsin digestion. Digestions
were done overnight in 25 mM ammonium bicarbonate at 30 °C, by adding 10 µL
endoproteinase (10 ng/µL) trypsin/LysC (Promega). Peptides were extracted by
ultrasonic with extraction solution (60% acetonitrile/5% formic acid). The
extraction was dried in a vacuum concentrator at room temperature. A second
round of propionylation was performed to propionylate the newly created peptide
N-termini. Sample were then loaded onto a homemade C18 StageTips. Peptides
were eluted from beads by incubation with 40/60 MeCN/H2O+ 0.1% formic acid.
The peptides were dried in a Speedvac and reconstituted in 10 µL 2/98 MeCN/
H2O+ 0.3% trifluoroacetic acid (TFA) prior to liquid chromatography–tandem
mass spectrometry (LC-MS/MS) analysis.
Peptide samples (5 µL) were chromatographically separated using an RSLCnano
system (Ultimate 3000, Thermo Scientific) coupled online to a Q Exactive HF-X
with a Nanospray Flex ion source (Thermo Scientific). Peptides were first trapped
on a C18 column (75-μm inner diameter × 2 cm; nanoViper Acclaim PepMapTM
100, Thermo Scientific), with buffer A at a flow rate of 2.5 µL/min over 4 min.
Separation was then performed on a C18 column (75-μm inner diameter × 50 cm;
nanoViper C18, 2 μm, 100 Å, Acclaim PepMapTM RSLC, Thermo Scientific)
regulated to a temperature of 50 °C with a linear gradient of 2 to 35% buffer B
(100% MeCN and 0.1 % formic acid) at a flow rate of 300 nL/min over 91 min. MS
full scans were performed in the ultrahigh-field Orbitrap mass analyzer in ranges
m/z 375–1500 with a resolution of 120,000 at m/z 200. The top 20 intense ions were
subjected to Orbitrap for further fragmentation via high-energy collision
dissociation (HCD) activation and a resolution of 15,000 with the intensity
threshold kept at 1 × 105. We selected ions with charge state from 2+ to 6+ for
screening. Normalized collision energy (NCE) was set at 27 and the dynamic
exclusion of 20 s.
For identification, the data were searched against the UniProt Paramecium
tetraurelia (downloaded on 10 September 2018 and containing 39,463 sequences)
database using Mascot (version 2.5.1). Enzyme specificity was set to trypsin and a
maximum of five-missed cleavage sites were allowed. Oxidized methionine, N-
terminal acetylation and Propionylation, Methyl lysine, Dimethyl lysine, Trimethyl
lysine, Propionyl lysine, Methyl-Propionyl lysine, and carbamidomethyl cysteine
were set as variable modifications. Maximum allowed mass deviation was set to 10
ppm for monoisotopic precursor ions and 0.02 Da for MS/MS peaks. The resulting
files were further processed using myProMS v3.6 (https://github.com/bioinfo-pf-
curie/myproms)59, where we fixed the false discovery rate for peptide identification
to <5%. All peptide identifications were manually inspected to ensure the quality of
the analysis.
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To quantify the modified peptides, we extracted from the MS survey of nano-LC-
MS/MS raw files the extracted ion chromatogram (XIC) signal of the well
characterized tryptic peptide ions using Skyline (version 4.1) MacCoss Lab Software,
Seattle, WA; https://skyline.ms/project/home/sofware/Skyline/begin.view). The
peptide XIC areas were log2 transformed and the mean log2- area was normalized by
the mean area of peptide A[Propionyl (N-term)]RTK[Propionyl (K)]QTAR using the
R statistical computing environment version 3.1.0. On each peptide a linear model
was used to estimate the mean and the 5% confidence interval of each condition. The
associated ratio and p-value have been computed thanks to a two-sided t-test with the
Welch approximation of the number of degrees of freedom.
Protein structure modeling. ClustalW60 was used for sequence alignment of
target human EZH2 (Q15910) sequence and template Ezl1 (PTET.51.1.G1740049)
sequence. Modeller v 9.1961 was used for comparative homology modeling of Ezl1
SET domain using the same criteria as in ref. 62. The structure of EZH2 in
interaction with the peptide substrate analog and the S-adenosylhomocysteine
(SAH) cofactor (PDB ID: 5HYN) was used as a template. Pymol molecular gra-
phics system (Version 1.7.2.1 Schrödinger, LLC) was used for comparative struc-
tural analysis between reference and modeled structures. Model quality was
analyzed using PROCHECK63.
RNA-seq data analysis. This study used the Paramecium tetraurelia strain 51
MAC (ptetraurelia_mac_51.fa) and MAC+ IES (ptetraurelia_mac_51_with_ies.fa)
reference assemblies, P. tetraurelia gene annotation version 234 and P. tetraurelia
IES annotation35. TE copies larger than 100 nt and not overlapping genes were
identified using the TEAnnot module of the REPET-2.5 package64 on the P. tet-
raurelia MIC contigs24, using a manually curated library of 61 TE consensus
sequences24. TEannot provides the percent identity between TE copies and the
consensus (used as a proxy for the age of the copy). Tandem repeats not over-
lapping genes or TE were identified on MIC contigs larger than 500 nt using
Tandem Repeat Finder24,65. Developmental genes were identified by RNA-seq DE
analysis of wild-type P. tetraurelia strain 5134. All reference genomes and fasta
librairies are available from ParameciumDB (https://paramecium.i2bc.paris-saclay.
fr/download/).
After removal of contaminants and rDNA by mapping the 100 nt paired-end
reads with bwa (default parameters), the RNA-seq reads were mapped using
TopHat (v. 2.0.12) on the MAC and the MAC+ IES reference genomes, allowing
two mismatches and requiring unique mapping in order to assure high specificity.
We used htseq-count (v. 0.6.0) to count fragments on the genes (and on the IESs
they contain). The reads that did not map on MAC or MAC+ IES references were
mapped using TopHat (–multihits= 1000 and allowing two mismatches) on the
MIC contigs. By allowing multiple hits, we avoid underestimating the expression of
repeated elements. Fragments mapped to TE copies and tandem repeats were
counted with htseq-count.
For differential expression analysis, fragment counts were normalized using the
45,682 elements (genes, TE copies and repeats) and DESeq2 (v. 1.14–1) in the R
statistical computing environment (R project v 3.3.2). PCA was carried out using the
R package FactoMineR (v. 1.34). Differential expression of genes and TE copies was
carried out with DESeq2, requiring a p-value < 0.05 and a fold-change > 2. Gene
heatmaps were made with the heatmap.2 and hclust R methods.
ChIP-seq data analysis. ChIP-seq data were demultiplexed using CASAVA
(v1.8.2) and bcl2fastq2 (v2.18.12). Illumina adapters were removed using cutadapt
(1.12), keeping only reads with a minimal length of ten nucleotides. Paired-end 80
nt reads were mapped (bowtie2.3.3) on expected contaminants (mitochondrial
genomes, ribosomal DNA, and bacterial genomes). PCR duplicates and low quality
reads (sickle v1.200 -q 20) were removed from the unmapped reads. Supplemen-
tary Table 5 shows the mapping statistics on Paramecium genomes (MAC: pte-
traurelia_mac_51.fa; MIC: ptetraurelia_mic2.fa) using bowtie2 v2.3.3 with mapping
quality >20. The data were also mapped on the 61 Paramecium TE consensus
sequences24 (bowtie2.3.3 default parameters) without any mapping quality
restriction. The coverage on each TE was calculated using bedtools (v2.17.0) then
normalized by a sequencing scale factor method.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
RNA-seq and ChIP-seq datasets generated for this study have been deposited at the ENA
with Study Accession number PRJEB21555. Supplementary Tables 1 and 5 describe the
samples, mapping statistics, and provide accession numbers for each sample. The mass
spectrometry proteomics data have been deposited to the ProteomeXchange Consortium
via the PRIDE66 partner repository with the data set identifier PXD012170. All other
relevant data supporting the key findings of this study are available within the article and
its Supplementary Information files or from the corresponding author upon reasonable
request. The source data underlying Figs. 2–5 and Supplementary Figs. 2 and 7 are
provided as a Source Data file. A reporting summary for this article is available as a
Supplementary Information file.
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